Levisetti Matteo has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 250000 shares of Cue Biopharma, Inc. ($CUE) on March 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 21, 2025 | Cue Biopharma, Inc. | $CUE | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,328,348 | 9999.99% | 0.44% |
| June 5, 2024 | Cue Biopharma, Inc. | $CUE | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 45,754,794 | 9999.99% | 0.27% |
| March 6, 2024 | Cue Biopharma, Inc. | $CUE | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 260000 | $0.00 | 260,000.0000 | 45,754,794 | 9999.99% | 0.57% |
| Feb. 20, 2024 | Cue Biopharma, Inc. | $CUE | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 45,754,794 | 9999.99% | 0.05% |